Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1996 Jan 1;313(Pt 1):289–295. doi: 10.1042/bj3130289

Recognition of lactoferrin and aminopeptidase M-modified lactoferrin by the liver: involvement of proteoglycans and the remnant receptor.

G J Ziere 1, J K Kruijt 1, M K Bijsterbosch 1, T J van Berkel 1
PMCID: PMC1216896  PMID: 8546697

Abstract

1. Lactoferrin and aminopeptidase M-modified lactoferrin (APM-lactoferrin; which lacks its 14 N-terminal amino acids) inhibit the liver uptake of lipoprotein remnant. In the present study, the role of proteoglycans in the initial interaction of beta-migrating very-low-density lipoprotein (beta-VLDL), native and APM-lactoferrin with isolated rat parenchymal liver cells was investigated. Treatment of the cells with chondroitinase lowered the Kd of lactoferrin binding (from 10 to 2.4 microM), and the number of sites/cell (from 20 x 10(6) to 7 x 10(6)), while heparinase treatment did not affect the binding. The binding characteristics of APM-lactoferrin and beta-VLDL were not altered by treatment of the cells with chondroitinase or heparinase. It is concluded that proteoglycans are not involved in the initial binding of APM-lactoferrin and beta-VLDL to parenchymal cells, while chondroitin sulphate proteoglycans are mainly responsible for the massive, low-affinity binding of native lactoferrin..2. The binding of lactoferrin, APM-lactoferrin and beta-VLDL to parenchymal liver cells was not influenced by the glutathione S-transferase-receptor-associated protein (GST-RAP) (97.2% +/- 4.0%, 95.5 +/- 3.7% and 98.5% of the control binding), while the binding of alpha 2-macroglobulin was fully blocked at 10 micrograms/ml GST-RAP (1.8 +/- 0.5% of the control binding). Since GST-RAP blocks the binding of all the known ligands to the low-density lipoprotein (LDL)-receptor-related protein (LRP), it is concluded that LRP is not the initial primary recognition site for lactoferrin, APM-lactoferrin and beta-VLDL on parenchymal liver cells. 3. We showed earlier that.APM-lactoferrin, as compared with lactoferrin, is a more effective inhibitor of the liver uptake of lipoprotein remnants (49.4 +/- 4.0% versus 80.8 +/- 4.8% of the control at 500 micrograms/ml respectively). We found in the present study that beta-VLDL is able to inhibit the binding of APM-lactoferrin to parenchymal liver cells significantly (74.9 +/- 3.3% of the control; P < 0.002), while the lactoferrin binding was unaffected. It is concluded that a still unidentified specific recognition site (the putative remnant receptor) is responsible for the initial binding of remnants to parenchymal cells and it is suggested that the partial cross-competition between APM-lactoferrin and beta-VLDL may be of further help in the elucidation of the molecular nature of this recognition site.

Full Text

The Full Text of this article is available as a PDF (519.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beisiegel U., Weber W., Bengtsson-Olivecrona G. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8342–8346. doi: 10.1073/pnas.88.19.8342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beisiegel U., Weber W., Ihrke G., Herz J., Stanley K. K. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature. 1989 Sep 14;341(6238):162–164. doi: 10.1038/341162a0. [DOI] [PubMed] [Google Scholar]
  3. Bennett R. M., Kokocinski T. Lactoferrin turnover in man. Clin Sci (Lond) 1979 Nov;57(5):453–460. doi: 10.1042/cs0570453. [DOI] [PubMed] [Google Scholar]
  4. Bensadoun A. Lipoprotein lipase. Annu Rev Nutr. 1991;11:217–237. doi: 10.1146/annurev.nu.11.070191.001245. [DOI] [PubMed] [Google Scholar]
  5. Bihain B. E., Yen F. T. Free fatty acids activate a high-affinity saturable pathway for degradation of low-density lipoproteins in fibroblasts from a subject homozygous for familial hypercholesterolemia. Biochemistry. 1992 May 19;31(19):4628–4636. doi: 10.1021/bi00134a013. [DOI] [PubMed] [Google Scholar]
  6. Bluard-Deconinck J. M., Williams J., Evans R. W., van Snick J., Osinski P. A., Masson P. L. Iron-binding fragments from the N-terminal and C-terminal regions of human lactoferrin. Biochem J. 1978 May 1;171(2):321–327. doi: 10.1042/bj1710321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Breton-Gorius J., Mason D. Y., Buriot D., Vilde J. L., Griscelli C. Lactoferrin deficiency as a consequence of a lack of specific granules in neutrophils from a patient with recurrent infections. Detection by immunoperoxidase staining for lactoferrin and cytochemical electron microscopy. Am J Pathol. 1980 May;99(2):413–428. [PMC free article] [PubMed] [Google Scholar]
  8. Choi S. Y., Fong L. G., Kirven M. J., Cooper A. D. Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo. J Clin Invest. 1991 Oct;88(4):1173–1181. doi: 10.1172/JCI115419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. De Water R., Kamps J. A., Van Dijk M. C., Hessels E. A., Kuiper J., Kruijt J. K., Van Berkel T. J. Characterization of the low-density-lipoprotein-receptor-independent interaction of beta-very-low-density lipoprotein with rat and human parenchymal liver cells in vitro. Biochem J. 1992 Feb 15;282(Pt 1):41–48. doi: 10.1042/bj2820041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gutteridge J. M., Paterson S. K., Segal A. W., Halliwell B. Inhibition of lipid peroxidation by the iron-binding protein lactoferrin. Biochem J. 1981 Oct 1;199(1):259–261. doi: 10.1042/bj1990259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hardingham T. E., Fosang A. J. Proteoglycans: many forms and many functions. FASEB J. 1992 Feb 1;6(3):861–870. [PubMed] [Google Scholar]
  12. Herz J., Goldstein J. L., Strickland D. K., Ho Y. K., Brown M. S. 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. J Biol Chem. 1991 Nov 5;266(31):21232–21238. [PubMed] [Google Scholar]
  13. Herz J., Hamann U., Rogne S., Myklebost O., Gausepohl H., Stanley K. K. Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J. 1988 Dec 20;7(13):4119–4127. doi: 10.1002/j.1460-2075.1988.tb03306.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Herz J., Kowal R. C., Goldstein J. L., Brown M. S. Proteolytic processing of the 600 kd low density lipoprotein receptor-related protein (LRP) occurs in a trans-Golgi compartment. EMBO J. 1990 Jun;9(6):1769–1776. doi: 10.1002/j.1460-2075.1990.tb08301.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Huettinger M., Retzek H., Eder M., Goldenberg H. Characteristics of chylomicron remnant uptake into rat liver. Clin Biochem. 1988 Apr;21(2):87–92. doi: 10.1016/s0009-9120(88)80093-6. [DOI] [PubMed] [Google Scholar]
  16. Huettinger M., Retzek H., Hermann M., Goldenberg H. Lactoferrin specifically inhibits endocytosis of chylomicron remnants but not alpha-macroglobulin. J Biol Chem. 1992 Sep 15;267(26):18551–18557. [PubMed] [Google Scholar]
  17. Ji Z. S., Brecht W. J., Miranda R. D., Hussain M. M., Innerarity T. L., Mahley R. W. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J Biol Chem. 1993 May 15;268(14):10160–10167. [PubMed] [Google Scholar]
  18. Ji Z. S., Mahley R. W. Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein. Further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG. Arterioscler Thromb. 1994 Dec;14(12):2025–2031. doi: 10.1161/01.atv.14.12.2025. [DOI] [PubMed] [Google Scholar]
  19. Karle H., Hansen N. E., Malmquist J., Karle A. K., Larsson I. Turnover of human lactoferrin in the rabbit. Scand J Haematol. 1979 Oct;23(4):303–312. doi: 10.1111/j.1600-0609.1979.tb02865.x. [DOI] [PubMed] [Google Scholar]
  20. Kowal R. C., Herz J., Goldstein J. L., Esser V., Brown M. S. Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc Natl Acad Sci U S A. 1989 Aug;86(15):5810–5814. doi: 10.1073/pnas.86.15.5810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kowal R. C., Herz J., Weisgraber K. H., Mahley R. W., Brown M. S., Goldstein J. L. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J Biol Chem. 1990 Jun 25;265(18):10771–10779. [PubMed] [Google Scholar]
  22. Lee B. R., Miller J. M., Yang C. Y., Ramdas L., Yang M. L., Morrisett J. D., Mims M. P. Amino acid sequence of rabbit apolipoprotein E. J Lipid Res. 1991 Jan;32(1):165–171. [PubMed] [Google Scholar]
  23. Lund H., Takahashi K., Hamilton R. L., Havel R. J. Lipoprotein binding and endosomal itinerary of the low density lipoprotein receptor-related protein in rat liver. Proc Natl Acad Sci U S A. 1989 Dec;86(23):9318–9322. doi: 10.1073/pnas.86.23.9318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Mahley R. W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988 Apr 29;240(4852):622–630. doi: 10.1126/science.3283935. [DOI] [PubMed] [Google Scholar]
  25. Masson P. L., Heremans J. F., Schonne E. Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J Exp Med. 1969 Sep 1;130(3):643–658. doi: 10.1084/jem.130.3.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. McFARLANE A. S. Efficient trace-labelling of proteins with iodine. Nature. 1958 Jul 5;182(4627):53–53. doi: 10.1038/182053a0. [DOI] [PubMed] [Google Scholar]
  27. Medh J. D., Fry G. L., Bowen S. L., Pladet M. W., Strickland D. K., Chappell D. A. The 39-kDa receptor-associated protein modulates lipoprotein catabolism by binding to LDL receptors. J Biol Chem. 1995 Jan 13;270(2):536–540. doi: 10.1074/jbc.270.2.536. [DOI] [PubMed] [Google Scholar]
  28. Metz-Boutigue M. H., Jollès J., Mazurier J., Schoentgen F., Legrand D., Spik G., Montreuil J., Jollès P. Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins. Eur J Biochem. 1984 Dec 17;145(3):659–676. doi: 10.1111/j.1432-1033.1984.tb08607.x. [DOI] [PubMed] [Google Scholar]
  29. Moestrup S. K., Gliemann J. Analysis of ligand recognition by the purified alpha 2-macroglobulin receptor (low density lipoprotein receptor-related protein). Evidence that high affinity of alpha 2-macroglobulin-proteinase complex is achieved by binding to adjacent receptors. J Biol Chem. 1991 Jul 25;266(21):14011–14017. [PubMed] [Google Scholar]
  30. Moguilevsky N., Retegui L. A., Courtoy P. J., Castracane C. E., Masson P. L. Uptake of lactoferrin by the liver. III. Critical role of the protein moiety. Lab Invest. 1984 Mar;50(3):335–340. [PubMed] [Google Scholar]
  31. Mokuno H., Brady S., Kotite L., Herz J., Havel R. J. Effect of the 39-kDa receptor-associated protein on the hepatic uptake and endocytosis of chylomicron remnants and low density lipoproteins in the rat. J Biol Chem. 1994 May 6;269(18):13238–13243. [PubMed] [Google Scholar]
  32. Mulder M., Lombardi P., Jansen H., van Berkel T. J., Frants R. R., Havekes L. M. Heparan sulphate proteoglycans are involved in the lipoprotein lipase-mediated enhancement of the cellular binding of very low density and low density lipoproteins. Biochem Biophys Res Commun. 1992 Jun 15;185(2):582–587. doi: 10.1016/0006-291x(92)91664-c. [DOI] [PubMed] [Google Scholar]
  33. Nykjaer A., Bengtsson-Olivecrona G., Lookene A., Moestrup S. K., Petersen C. M., Weber W., Beisiegel U., Gliemann J. The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds lipoprotein lipase and beta-migrating very low density lipoprotein associated with the lipase. J Biol Chem. 1993 Jul 15;268(20):15048–15055. [PubMed] [Google Scholar]
  34. Prieels J. P., Pizzo S. V., Glasgow L. R., Paulson J. C., Hill R. L. Hepatic receptor that specifically binds oligosaccharides containing fucosyl alpha1 leads to 3 N-acetylglucosamine linkages. Proc Natl Acad Sci U S A. 1978 May;75(5):2215–2219. doi: 10.1073/pnas.75.5.2215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Querinjean P., Masson P. L., Heremans J. F. Molecular weight, single-chain structure and amino acid composition of human lactoferrin. Eur J Biochem. 1971 Jun 11;20(3):420–425. doi: 10.1111/j.1432-1033.1971.tb01408.x. [DOI] [PubMed] [Google Scholar]
  36. Retegui L. A., Moguilevsky N., Castracane C. F., Masson P. L. Uptake of lactoferrin by the liver. I. Role of the reticuloendothelial system as indicated by blockade experiments. Lab Invest. 1984 Mar;50(3):323–328. [PubMed] [Google Scholar]
  37. Rumsey S. C., Obunike J. C., Arad Y., Deckelbaum R. J., Goldberg I. J. Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages. J Clin Invest. 1992 Oct;90(4):1504–1512. doi: 10.1172/JCI116018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Seglen P. O. Preparation of isolated rat liver cells. Methods Cell Biol. 1976;13:29–83. doi: 10.1016/s0091-679x(08)61797-5. [DOI] [PubMed] [Google Scholar]
  39. Stow J. L., Kjéllen L., Unger E., Hök M., Farquhar M. G. Heparan sulfate proteoglycans are concentrated on the sinusoidal plasmalemmal domain and in intracellular organelles of hepatocytes. J Cell Biol. 1985 Mar;100(3):975–980. doi: 10.1083/jcb.100.3.975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Strickland D. K., Ashcom J. D., Williams S., Battey F., Behre E., McTigue K., Battey J. F., Argraves W. S. Primary structure of alpha 2-macroglobulin receptor-associated protein. Human homologue of a Heymann nephritis antigen. J Biol Chem. 1991 Jul 15;266(20):13364–13369. [PubMed] [Google Scholar]
  41. Strickland D. K., Ashcom J. D., Williams S., Burgess W. H., Migliorini M., Argraves W. S. Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J Biol Chem. 1990 Oct 15;265(29):17401–17404. [PubMed] [Google Scholar]
  42. Van Tol A., Van 't Hooft F. M., Van Gent T. Discrepancies in the catabolic pathways of rat and human low density lipoproteins as revealed by partial hepatectomy in the rat. Atherosclerosis. 1978 Apr;29(4):449–457. doi: 10.1016/0021-9150(78)90173-9. [DOI] [PubMed] [Google Scholar]
  43. Williams K. J., Fless G. M., Petrie K. A., Snyder M. L., Brocia R. W., Swenson T. L. Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans. J Biol Chem. 1992 Jul 5;267(19):13284–13292. [PubMed] [Google Scholar]
  44. Willnow T. E., Goldstein J. L., Orth K., Brown M. S., Herz J. Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J Biol Chem. 1992 Dec 25;267(36):26172–26180. [PubMed] [Google Scholar]
  45. Yamagata T., Saito H., Habuchi O., Suzuki S. Purification and properties of bacterial chondroitinases and chondrosulfatases. J Biol Chem. 1968 Apr 10;243(7):1523–1535. [PubMed] [Google Scholar]
  46. Yen F. T., Mann C. J., Guermani L. M., Hannouche N. F., Hubert N., Hornick C. A., Bordeau V. N., Agnani G., Bihain B. E. Identification of a lipolysis-stimulated receptor that is distinct from the LDL receptor and the LDL receptor-related protein. Biochemistry. 1994 Feb 8;33(5):1172–1180. doi: 10.1021/bi00171a017. [DOI] [PubMed] [Google Scholar]
  47. Ziere G. J., Bijsterbosch M. K., van Berkel T. J. Removal of 14 N-terminal amino acids of lactoferrin enhances its affinity for parenchymal liver cells and potentiates the inhibition of beta- very low density lipoprotein binding. J Biol Chem. 1993 Dec 25;268(36):27069–27075. [PubMed] [Google Scholar]
  48. Ziere G. J., van Dijk M. C., Bijsterbosch M. K., van Berkel T. J. Lactoferrin uptake by the rat liver. Characterization of the recognition site and effect of selective modification of arginine residues. J Biol Chem. 1992 Jun 5;267(16):11229–11235. [PubMed] [Google Scholar]
  49. van Dijk M. C., Ziere G. J., Boers W., Linthorst C., Bijsterbosch M. K., van Berkel T. J. Recognition of chylomicron remnants and beta-migrating very-low-density lipoproteins by the remnant receptor of parenchymal liver cells is distinct from the liver alpha 2-macroglobulin-recognition site. Biochem J. 1991 Nov 1;279(Pt 3):863–870. doi: 10.1042/bj2790863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. van Dijk M. C., Ziere G. J., van Berkel T. J. Characterization of the chylomicron-remnant-recognition sites on parenchymal and Kupffer cells of rat liver. Selective inhibition of parenchymal cell recognition by lactoferrin. Eur J Biochem. 1992 Apr 15;205(2):775–784. doi: 10.1111/j.1432-1033.1992.tb16842.x. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES